Cargando…
Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis?
The elimination of tuberculosis (TB) cannot reasonably be achieved by treatment of individual cases and will require an improved vaccine or immunotherapy. A challenge in developing an improved TB vaccine has been the lack of understanding what is needed to generate sterilizing immunity against Mycob...
Autores principales: | Meermeier, Erin W., Lewinsohn, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974584/ https://www.ncbi.nlm.nih.gov/pubmed/29904578 http://dx.doi.org/10.12688/f1000research.13224.1 |
Ejemplares similares
-
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion
por: Simmons, Jason D., et al.
Publicado: (2022) -
Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis
por: Vyas, Sunil, et al.
Publicado: (2015) -
Comparing Interferon-Gamma Release Assays to Tuberculin Skin Test in Thai Children with Tuberculosis Exposure
por: Tieu, Hong-Van, et al.
Publicado: (2014) -
Private sector tuberculosis prevention in the US: Characteristics associated with interferon-gamma release assay or tuberculin skin testing
por: Stockbridge, Erica L., et al.
Publicado: (2018) -
Tuberculin Skin Testing and Treatment Modulates Interferon-Gamma Release Assay Results for Latent Tuberculosis in Migrants
por: O'Shea, Matthew K., et al.
Publicado: (2014)